Onclarity™ Self-Collection Kit
Device For Home Collection And Transport Of Vaginal Specimens By Lay Users For Use In An Approved Hpv Molecular Assay. 510(k) K260184, from Becton, Dickinson and Company (Sparks, MD). Product code SEP, class 2.
As of Nov 20, 2026, K260184 is an FDA 510(k) held by Becton, Dickinson and Company, substantially equivalent on Apr 2, 2026 after 71 days, with no recalls tied to it in FDA's recall database.
- Review time: 71 days
- Recalls: 0
The Onclarity™ Self-Collection Kit is intended for the self-collection and transport of vaginal specimens for use with an FDA approved HPV molecular assay with which the collection device has been validated. The Onclarity™ Self- Collection Kit contains all of the necessary components for the self-collection of a vaginal specimen in a home or private setting.
- Teal WandDEN240045 · Teal Health, Inc. · May 9, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 21, 2026
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2920
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files